Triastek

Global leader in 3D printing pharmaceuticals

Nanjing, China · Founded 2015 · $90.9M raised

Headquarters
Nanjing
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$90.9M
Last Round
$50.0M Series BSep 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Triastek is a global leader in 3D printing pharmaceuticals, founded in July 2015 and headquartered in Nanjing, China. The company pioneered Melt Extrusion Deposition (MED), a proprietary 3D printing technology platform designed to manufacture precision drug products with programmable release profiles. Triastek's technology enables unique drug delivery solutions that improve patient outcomes and has received IND clearance from the FDA. The company collaborates with major pharmaceutical partners — including a research and license agreement with BioNTech for 3D-printed oral RNA therapeutics — and is advancing commercialization of its platform across global pharmaceutical markets.

Summary

Triastek is a Biotech company based in Nanjing, China, founded in 2015. It has raised $90.9M in total across 3 rounds, most recently a $50.0M Series B round in Sep 2023. Investors include Matrix Partners China, CPE Capital and Morningside Group.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2023
$20.5M

Sign up to see all 3 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Triastek on Indexed.vc
<a href="https://indexed.vc/companies/triastek"><img src="https://indexed.vc/api/badge/company/triastek" alt="Triastek on Indexed.vc" width="260" height="76" /></a>